Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1977 1
1979 1
1983 1
1985 3
1986 5
1988 1
1989 2
1990 1
1991 1
1992 2
1993 3
1994 1
1995 1
1997 2
1998 4
1999 2
2000 2
2001 1
2002 4
2003 4
2004 1
2005 4
2006 7
2007 5
2008 8
2009 8
2010 8
2011 7
2012 11
2013 11
2014 16
2015 8
2016 11
2017 9
2018 8
2019 11
2020 11
2021 11
2022 12
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Glycerol metabolism disease"
Page 1
Early prediction of phenotypic severity in Citrullinemia Type 1.
Zielonka M, Kölker S, Gleich F, Stützenberger N, Nagamani SCS, Gropman AL, Hoffmann GF, Garbade SF, Posset R; Urea Cycle Disorders Consortium (UCDC) and the European Registry and Network for Intoxication type Metabolic Diseases (E-IMD) Consortia Study Group. Zielonka M, et al. Ann Clin Transl Neurol. 2019 Sep;6(9):1858-1871. doi: 10.1002/acn3.50886. Epub 2019 Aug 30. Ann Clin Transl Neurol. 2019. PMID: 31469252 Free PMC article.
OBJECTIVE: Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn screening. The clinical spectrum is highly variable including individuals with lethal hyperammonemic encephalopathy in the newborn period and …
OBJECTIVE: Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn s …
Serum integrative omics reveals the landscape of human diabetic kidney disease.
Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, Zhang K, Yu Y, Xiao L, Qiao Y, Bonin C, Hargis G, Huan T, Yu Y, Tao J, Zhang R, Kreutzer DL, Zhou Y, Tian XJ, Wang Y, Fu H, An X, Liu S, Zhou D. Liu S, et al. Mol Metab. 2021 Dec;54:101367. doi: 10.1016/j.molmet.2021.101367. Epub 2021 Nov 1. Mol Metab. 2021. PMID: 34737094 Free PMC article. Clinical Trial.
OBJECTIVE: Diabetic kidney disease (DKD) is the most common microvascular complication of type 2 diabetes mellitus (2-DM). ...First, the training proteomics revealed that the combination of alpha(2)-macroglobulin, cathepsin D, and CD324 could serve as a surrogate protein b …
OBJECTIVE: Diabetic kidney disease (DKD) is the most common microvascular complication of type 2 diabetes mellitus (2-DM). ...First, …
Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency.
Scharre S, Posset R, Garbade SF, Gleich F, Seidl MJ, Druck AC, Okun JG, Gropman AL, Nagamani SCS, Hoffmann GF, Kölker S, Zielonka M; Urea Cycle Disorders Consortium (UCDC) and the European registry and network for Intoxication type Metabolic Diseases (E-IMD) Consortia Study Group. Scharre S, et al. Ann Clin Transl Neurol. 2022 Nov;9(11):1715-1726. doi: 10.1002/acn3.51668. Epub 2022 Oct 10. Ann Clin Transl Neurol. 2022. PMID: 36217298 Free PMC article.
OBJECTIVE: Ornithine transcarbamylase deficiency (OTC-D) is an X-linked metabolic disease and the most common urea cycle disorder. Due to high phenotypic heterogeneity, ranging from lethal neonatal hyperammonemic events to moderate symptoms and even asymptomatic ind …
OBJECTIVE: Ornithine transcarbamylase deficiency (OTC-D) is an X-linked metabolic disease and the most common urea cycle disor …
Glycerol-3-phosphate phosphatase/PGP: Role in intermediary metabolism and target for cardiometabolic diseases.
Possik E, Madiraju SRM, Prentki M. Possik E, et al. Biochimie. 2017 Dec;143:18-28. doi: 10.1016/j.biochi.2017.08.001. Epub 2017 Aug 5. Biochimie. 2017. PMID: 28826615 Review.
Metabolic diseases, including obesity, type 2 diabetes, and metabolic syndrome arise because of disturbances in glucose and fat metabolism, which impact associated physiological events such as insulin secretion and action, fat storage and oxidation. .. …
Metabolic diseases, including obesity, type 2 diabetes, and metabolic syndrome arise because of disturbances in glucose …
Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications.
Yadav E, Yadav N, Hus A, Yadav JS. Yadav E, et al. Respir Med. 2020 Nov-Dec;174:106193. doi: 10.1016/j.rmed.2020.106193. Epub 2020 Oct 17. Respir Med. 2020. PMID: 33096317 Free PMC article. Review.
Subsequent studies have highlighted the functional significance of AQPs, particularly AQP1 and AQP5 in lung pathophysiology and diseases, including but not limited to chronic and acute lung injury, chronic obstructive pulmonary disease (COPD), other inflammatory lun …
Subsequent studies have highlighted the functional significance of AQPs, particularly AQP1 and AQP5 in lung pathophysiology and diseases …
SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study.
Lv Y, Cheng X, Dong Q. Lv Y, et al. Cardiovasc Diabetol. 2024 May 7;23(1):157. doi: 10.1186/s12933-024-02255-6. Cardiovasc Diabetol. 2024. PMID: 38715111 Free PMC article.
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulating metabolites beyond glucose regulation, which could contribute to a reduction in the burden of cerebral small vessel disease (CSVD) …
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) and SGLT1 inhibitors may have additional beneficial metabolic effects on circulati …
1H qNMR-Based Metabolomics Discrimination of Covid-19 Severity.
Correia BSB, Ferreira VG, Piagge PMFD, Almeida MB, Assunção NA, Raimundo JRS, Fonseca FLA, Carrilho E, Cardoso DR. Correia BSB, et al. J Proteome Res. 2022 Jul 1;21(7):1640-1653. doi: 10.1021/acs.jproteome.1c00977. Epub 2022 Jun 8. J Proteome Res. 2022. PMID: 35674498
Six polar metabolites (glycerol, acetate, 3-aminoisobutyrate, formate, glucuronate, and lactate) were revealed by PLS-DA and predicted by ROC curves and ANOVA to be potential prognostic metabolite panels for Covid-19 and considered clinically relevant for …
Six polar metabolites (glycerol, acetate, 3-aminoisobutyrate, formate, glucuronate, and lactate) were revealed by PLS-DA and predi …
Research progress of fibroblast growth factor 23 in acute kidney injury.
Zhang L, Qin W. Zhang L, et al. Pediatr Nephrol. 2023 Jul;38(7):2013-2022. doi: 10.1007/s00467-022-05791-z. Epub 2022 Nov 22. Pediatr Nephrol. 2023. PMID: 36416954 Free PMC article. Review.
Fibroblast growth factor 23 (FGF23) is primarily produced in bones and mainly regulates calcium and phosphorus metabolism. The level of circulating FGF23 increases rapidly in the early stage of acute kidney injury (AKI). Recent studies have shown that FGF23 may serve as a …
Fibroblast growth factor 23 (FGF23) is primarily produced in bones and mainly regulates calcium and phosphorus metabolism. The level …
Application of Metabolic Profiling to Abdominal Aortic Aneurysm Research.
Qureshi MI, Greco M, Vorkas PA, Holmes E, Davies AH. Qureshi MI, et al. J Proteome Res. 2017 Jul 7;16(7):2325-2332. doi: 10.1021/acs.jproteome.6b00894. Epub 2017 Jun 19. J Proteome Res. 2017. PMID: 28287739 Free article. Review.
Aminomalonic acid, guanidinosuccinic acid, and glycerol emerge as potential plasma biomarkers of large aneurysm. Lipid profiling improves predictive models of aneurysm presence. ...Significant limitations include small study sizes, lack of correction for multiple te …
Aminomalonic acid, guanidinosuccinic acid, and glycerol emerge as potential plasma biomarkers of large aneurysm. Lipid profiling impr …
The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker.
da Silva IV, Garra S, Calamita G, Soveral G. da Silva IV, et al. Biomolecules. 2022 Jun 27;12(7):897. doi: 10.3390/biom12070897. Biomolecules. 2022. PMID: 35883453 Free PMC article. Review.
Aquaporin-9 (AQP9) is the most expressed in the liver, with implications in general metabolic and redox balance due to its aquaglyceroporin and peroxiporin activities, facilitating glycerol and hydrogen peroxide (H(2)O(2)) diffusion across membranes. ...The present …
Aquaporin-9 (AQP9) is the most expressed in the liver, with implications in general metabolic and redox balance due to its aquaglycer …
204 results